Top Ranked Income Stocks to Buy for April 8th

Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 8th:

AbbVie Inc. (ABBV): This biopharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.5% over the last 60 days.

AbbVie Inc. Price and Consensus

AbbVie Inc. Price and Consensus
AbbVie Inc. Price and Consensus

AbbVie Inc. price-consensus-chart | AbbVie Inc. Quote

This Zacks Rank #2 (Buy) company has a dividend yield of 6.26%, compared with the industry average of 2.83%. Its five-year average dividend yield is 4.1%.

AbbVie Inc. Dividend Yield (TTM)

AbbVie Inc. Dividend Yield (TTM)
AbbVie Inc. Dividend Yield (TTM)

AbbVie Inc. dividend-yield-ttm | AbbVie Inc. Quote

Cardinal Health, Inc. (CAH): This integrated healthcare services and products company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.9% over the last 60 days.

Cardinal Health, Inc. Price and Consensus

Cardinal Health, Inc. Price and Consensus
Cardinal Health, Inc. Price and Consensus

Cardinal Health, Inc. price-consensus-chart | Cardinal Health, Inc. Quote

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 4.02%, compared with the industry average of 0.00%. Its five-year average dividend yield is 2.9%.

Cardinal Health, Inc. Dividend Yield (TTM)

Cardinal Health, Inc. Dividend Yield (TTM)
Cardinal Health, Inc. Dividend Yield (TTM)

Cardinal Health, Inc. dividend-yield-ttm | Cardinal Health, Inc. Quote

Rocky Brands, Inc. (RCKY): This designer and manufacturer of footwear and apparel has witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.5% over the last 60 days.

Rocky Brands, Inc. Price and Consensus

Rocky Brands, Inc. Price and Consensus
Rocky Brands, Inc. Price and Consensus

Rocky Brands, Inc. price-consensus-chart | Rocky Brands, Inc. Quote

This Zacks Rank #1 (Strong Buy) company has a dividend yield of 3.04%, compared with the industry average of 1.31%. Its five-year average dividend yield is 2.72%.

Rocky Brands, Inc. Dividend Yield (TTM)

Rocky Brands, Inc. Dividend Yield (TTM)
Rocky Brands, Inc. Dividend Yield (TTM)

Rocky Brands, Inc. dividend-yield-ttm | Rocky Brands, Inc. Quote

HP Inc. (HPQ): This provider of personal computing and other access devices, imaging and printing products has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.4% over the last 60 days.

HP Inc. Price and Consensus

HP Inc. Price and Consensus
HP Inc. Price and Consensus

HP Inc. price-consensus-chart | HP Inc. Quote

This Zacks Rank #2 (Buy) company has a dividend yield of 4.66%, compared with the industry average of 2.00%. Its five-year average dividend yield is 3.1%.

HP Inc. Dividend Yield (TTM)

HP Inc. Dividend Yield (TTM)
HP Inc. Dividend Yield (TTM)

HP Inc. dividend-yield-ttm | HP Inc. Quote

See the full list of top ranked stocks here.

Find more top income stocks with some of our great premium screens.

Free: Zacks’ Single Best Stock Set to Double

Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.

This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.

See 5 Stocks Set to Double>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Rocky Brands, Inc. (RCKY) : Free Stock Analysis Report
 
HP Inc. (HPQ) : Free Stock Analysis Report
 
Cardinal Health, Inc. (CAH) : Free Stock Analysis Report
 
AbbVie Inc. (ABBV) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement